Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP-4 inhibitor combined with insulin in type 2 diabetes
ChiCTR1900024414Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Bengbu Medical University
- Start
- Aug 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of saxagliptin, human insulin and metformin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by First Affiliated Hospital of Bengbu Medical University. Primary endpoints: blood glucose, glycosylated hemoglobin and 10 more. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
saxagliptinhuman insulinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900024414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024414.